NEW YORK (GenomeWeb) – High-sensitivity immunoassay firm Quanterix announced on its Q4 earnings call this week that it has acquired microarray company Aushon BioSystems.

Kevin Hrusovsky, Quanterix's executive chairman and CEO, said during the call that in the near term the deal gives Quanterix access to Aushon's CLIA facility and allows it to bring aboard a number of Aushon employees it had hoped to hire this year.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.